- March 11, 2010
- 04:50 AM CET
- search
- Disclaimer
- PRIVACY POLICY
- Imprint
- RSS
- ©2010 EVOTEC
- Loading...
Archive
Evotec Reports Good Progress in Product Development in Treatment-Resistant Depression in its Alliance with Roche
10 March 2010
Successful completion of first-in-man study with EVT 103 - Positive feedback from the FDA to initiate Phase II with EVT 101...
Evotec AG: Fiscal Year 2009 Results Presentation on 25 March 2010 Live on the Internet
1 March 2010: Evotec AG going to broadcast its press & analyst conference in Frankfurt live on the internet. The Management Board of Evotec AG will inform you about the ...
- read moreEvotec Extends and Broadens Research Agreement with Cubist Pharmaceuticals
25 February 2010
Collaboration expanded to include integrated fragment-based drug discovery activities on additional antibacterial targets: Evotec AG today announced that it has extended its research agreement with Cubist Pharmaceuticals, Inc...
Evotec and Vifor Pharma Sign Major Cooperation Agreement
2 February 2010
Development of preclinical candidate in the field of anaemia, Evotec to provide integrated biology, chemistry and preclinical development activities, Project worth in excess of EUR 5.5 million ...
Evotec and CHDI Foundation, Inc. Extend Collaboration to Fight Huntington's Disease
14 January 2010
Strategic alliance with CHDI aimed at accelerating efforts to develop drugs against Huntington's disease - Entails research revenue of up to US$ 37.5 million over the next three years - One of the largest strategic drug disc...